LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Yasmin Side Effects Affect Otherwise Healthy Women
Mar-5-13 Santa Fe, NM Women determining whether or not to use Yasmin birth control or other drospirenone-containing birth control may have been moved by ads marketing the contraceptives without realizing there was a risk of Yasmin side effects. Those side effects include a risk of blood clots, a risk that exists in other birth control pills but is reportedly mu... - Massive Hip & Knee Failure Rates, First Trial Underway in California
Feb-24-13 Los Angeles, CA The perception that all-metal implants would be an improvement over plastic artificial hips and knees appears to have proven just that. Reality has not mirrored perception, with metal-on-metal devices not only failing to last beyond the 15-year life expectancy of more traditional implants, but actually failing in a matter of months. Hip a... - Study Suggests SNRI Effexor Linked to Birth Defects
Feb-22-13 Atlanta, GA A recently published study seems to confirm concerns that SNRI side effects could include a risk of SNRI birth defects. The study, which involved Effexor, a serotonin-norepinephrine reuptake inhibitor (SNRI), found statistically significant associations between the use of Effexor during early pregnancy and having a baby with a birth defect... - Beyond Mirena Uterine Perforation, An IUD That Travels
Feb-14-13 Morris County, NJ Much has been written about the benefits of so-called “long-acting reversible contraceptives” such as IUD devices like Mirena, with the IUDs leading the way with 8.5 percent of US women, according to the not-for-profit Guttmacher Institute. USA TODAY (10/30/12) cited recent federal data that agreed with the Guttmacher findin... - The Pressure’s On AstraZeneca and Nexium
Feb-13-13 Boston, MA The manufacturer of a popular acid reflux drug, Nexium, appears to be in a state of flux with various issues percolating inherent with the pharmaceutical company. AstraZeneca , with a new leader at the helm, has reportedly axed thousands of jobs and is facing diminished returns from Nexium sales when the patent on the prescription version of... - Medtronic Infuse Causes Litany of Complications
Feb-11-13 Portland, OR Alan is one of half a million patients who had a Medtronic Infuse bone graft and thereby contributed to Medtronic’s sales of $800 million in fiscal 2011. Now Medtronic might want to put aside some of those profits for Medtronic lawsuits. Alan is also one of many patients who have suffered Medtronic complications that range from diffi... - Attorney says There’s Light at the End of the Hip and Knee Lawsuit Tunnel
Feb-10-13 Los Angeles, CA The first DePuy ASR trial is now underway in Los Angeles. Dr Shezad Malik, hip and knee attorney says that “plaintiffs are quietly confident they will prevail at trial based on the Johnson & Johnson smoking gun internal documents and based on the testimony of the plaintiffs’ experts.” Dr Malik explains that ri... - New Diabetes Drug May Compete with Januvia
Feb-2-13 Washington, DC The US Food and Drug Administration (FDA) has approved a new diabetes drug that is expected to compete with Januvia for a share of the diabetes medication market. Although the drug is believed to have heart risks, it is not yet known if the drug’s risks are similar to Januvia side effects. Some studies have suggested a link between... - J&J Knew DePuy ASR Hip Replacement Would Fail
Jan-23-13 New York, NY Johnson & Johnson’s (J&J) artificial hip replacement, the Articular Surface Replacement (ASR), was estimated to fail in approximately 40 percent of patients, based on data from its own internal analysis, made public for the first time this week. The document is one of hundreds of internal company documents expected to become public over... - Medtronic Infuse Patient Worse After Surgery
Jan-15-13 Myrtle Beach, SC Pansy says she was trained in surgical procedures so she did everything to avoid spinal surgery. But she wasn’t trained in the side effects of Medtronic Infuse bone graft. “I understand that spinal surgery is dangerous because you risk paralysis but my orthopedic surgeon said I had no choice if I wanted to relieve the pa... - What Will 2013 Hold For Yasmin Birth Control?
Jan-3-13 St. Clair County, IL It's been a year since US District Judge David Herndon decided to postpone the trial associated with a Yasmin lawsuit in an effort to have the thousands of cases mediated instead, with the view of reaching a settlement. That effort with regard to Yasmin birth control, as well as Yaz lawsuits, resulted in the November 2012 settle... - Chantix Aggression, And the Role Prescription Drugs Can Play
Dec-31-12 Newtown, CT As 2012 comes to a close, the horrific massacre at Sandy Hook Elementary School in Newtown, Connecticut continues to galvanize public opinion on everything from the availability of guns, to the reasons why a young man like Adam Lanza might be driven to undertake such a shocking assault on human life. And while the debate rages over the gun issu... - Latest Study Suggests Lexapro et al Carry No Benefit For Pregnant Women and Babies
Dec-30-12 Boston, MA While experts agree that attempting a thorough clinical trial into SSRI antidepressants on pregnant women is ethically questionable, researchers continue to search for answers to a long-debated question: are depression patients who become pregnant better off without their antidepressants in an attempt to avoid the possibility of Lexapro birth... - “Better Off with Ohio Minimum Wage,” says Independent Contractor
Dec-20-12 Columbus, OH Alex says he would be better off getting minimum wage of $7.70 per hour according to Ohio employment law than how some independent contractors are paid. And he would be better protected by Ohio Employment Law. Before Alex started working as a satellite TV installer for Solutions Contractor Inc., one of Direct TV’s contractors, he... - Were Women Put at Risk of Yasmin Side Effects by Lack of Disclosure?
Dec-16-12 Seattle, WA When women make decisions about whether to use Yasmin birth control and other medications, they assume they have all the pertinent information to help them make that decision. That includes information about the risk of Yasmin side effects and any links between Yasmin and DVT or other serious complications. When drug companies fail to provi... - Consumer Reports Concerned About Bisphosphonate Drugs
Dec-15-12 Yonkers, NY The iconic consumer magazine, Consumer Reports has long been known for compiling the best buys in terms of electronics, automotives and other consumer goods. Lately Consumers Union, which publishes the bastion of consumer advocacy, has been setting its sights on pharmaceutical drugs and medical products. And Consumer Reports has let it be k... - Chantix Increases Risk of Major Cardiovascular Events, FDA Warns
Dec-13-12 Washington, DC People taking the smoking cessation drug Chantix (varenicline) may have a higher risk of suffering major adverse cardiovascular events, according to information issued by the Food and Drug Administration this week. The results support earlier findings. The data are from a large, combined analysis (meta-analysis) of clinical trials tha... - Until The Bleeding Stops, Pradaxa Side Effects Remain a Concern
Dec-10-12 Walnut Creek, CA With Pradaxa side effects , it's one step forward, two steps back: while doctors were buoyed by the availability of an alternative to Coumadin (warfarin) for thinning of the blood, the potential for Pradaxa patients to perish from uncontrollable bleeding is a sobering reality. The San Francisco Chronicle (11/28/12) notes that resea... - Are SSRI Medications Worth the Risk?
Nov-28-12 Waltham, MA A recent study suggests the risk of Zoloft side effects may not be worth the benefits. The study focused on SSRI medications, a class of drugs that includes Zoloft and suggests that the risks of Zoloft birth defects and other adverse reactions may outweigh any potential benefits. The study was published October 31 in Human Reproduction... - Actos Among Group of Four With Higher Reports of Side Effects
Nov-24-12 Horsham, PA As concern over Actos bladder cancer mounts, an independent drug watchdog reports that Takeda's Actos is among four drugs that have incurred sharp increases in adverse reactions. The time frame scrutinized by the Institute for Safe Medications Practices (ISMP) covers the first quarter (Q1) of 2012 as compared with the same period a year...